Sanofi India Ltd - 500674 - Divestment Of Soframycin(r) And Sofradex(r) Businesses
Please find enclosed announcement related to - Divestment of Soframycin(r) and Sofradex(r) businesses of the Company which is self explanatory for your information and records Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Resignation of Director
As required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company has received a letter today, from Mr. Cyril Grandchamp-Desraux stating that he would like to resign as the Non-Executive Director of the Company due to personal reasons with immediate effect from 24th November 2021. (date of receipt of letter). The Company places on record its appreciation for the contribution made by Mr. Cyril Grandchamp-Desraux during his tenure as Non-Executive Director of the Company. Please take the above information on record. Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates in lieu of the original share certificates reported lost/misplaced, details of which are enclosed. Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed. Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed. Sanofi India Ltd - 500674 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates in lieu of the original share certificates reported lost/misplaced, details of which are enclosed: Sanofi India Ltd - 500674 - Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
As required under regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors has authorised the Managing Director and Chief Financial Officer to determine materiality of an event or information in line with the said Regulations. The Board has also authorised the Company Secretary to disclose such information to the Stock Exchanges. The contact details of the above officials are as enclosed. Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed:
